Last reviewed · How we verify

NCT03030677: ETCI

Establishing Technique for PECS2 Catheter Insertion

Completed NA Last updated 9 September 2020
What this trial tests

NA trial testing Pectoralis II block & catheter without Lidocaine dissection in Breastcancer in 80 participants. Completed in 30 November 2019.

Timeline
1 November 2018
Primary endpoint
31 August 2019
30 November 2019

Quick facts

Lead sponsorKasr El Aini Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment80
Start date1 November 2018
Primary completion31 August 2019
Estimated completion30 November 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Kasr El Aini Hospital

Who can join

Adults 21 to 60, female only, with Breastcancer or Phyllodes Breast Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators are trying to establish an easy technique for insertion of a catheter for continuous infusion while performing pectoral type 2 (serratus) block, as a post operative pain controlling measure for cases undergoing simple mastectomy, using ultrasound guidence

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Establishing a Technique for Pectoral II-Block Catheter Insertion with Ultrasound Guidance: A Randomized Controlled Trial.
    Mansour MA, Fouad AZ, Amin SM, Dobal NM. · · 2020 · cited 1× · PMID 32848451 · DOI 10.2147/lra.s262138

Verify or expand the search:

Other recruiting trials for Breastcancer

Currently open trials in the same condition.

Other Kasr El Aini Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03030677.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing